3. GOOD HEALTH AND WELL-BEING

Maximus, Inc. (NYSE:MMS) Shares Acquired by US Bancorp DE

Written by Amanda

US Bancorp DE boosted its position in Maximus, Inc. (NYSE:MMSFree Report) by 20.3% in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 9,843 shares of the health services provider’s stock after purchasing an additional 1,664 shares during the period. US Bancorp DE’s holdings in Maximus were worth $825,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. Norges Bank bought a new stake in shares of Maximus in the 4th quarter worth approximately $55,821,000. FMR LLC increased its holdings in shares of Maximus by 6.4% in the third quarter. FMR LLC now owns 8,588,189 shares of the health services provider’s stock valued at $641,366,000 after buying an additional 514,698 shares in the last quarter. Knights of Columbus Asset Advisors LLC increased its holdings in shares of Maximus by 346.3% in the fourth quarter. Knights of Columbus Asset Advisors LLC now owns 118,290 shares of the health services provider’s stock valued at $9,920,000 after buying an additional 91,788 shares in the last quarter. Dimensional Fund Advisors LP lifted its position in shares of Maximus by 8.1% during the 4th quarter. Dimensional Fund Advisors LP now owns 1,062,173 shares of the health services provider’s stock valued at $89,075,000 after acquiring an additional 79,729 shares during the last quarter. Finally, SG Capital Management LLC bought a new stake in shares of Maximus during the 3rd quarter worth $5,951,000. 97.21% of the stock is owned by institutional investors.

Maximus Stock Up 0.1 %

Shares of NYSE:MMS opened at $86.86 on Thursday. The firm has a 50 day simple moving average of $83.10 and a 200 day simple moving average of $82.91. Maximus, Inc. has a 52 week low of $72.39 and a 52 week high of $90.65. The company has a debt-to-equity ratio of 0.63, a quick ratio of 1.53 and a current ratio of 1.53. The company has a market cap of $5.28 billion, a PE ratio of 22.80 and a beta of 0.74.

Maximus (NYSE:MMSGet Free Report) last released its earnings results on Wednesday, May 8th. The health services provider reported $1.57 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.31 by $0.26. Maximus had a return on equity of 18.02% and a net margin of 4.58%. The company had revenue of $1.35 billion during the quarter, compared to analyst estimates of $1.29 billion. During the same quarter in the prior year, the company earned $0.80 earnings per share. The company’s revenue for the quarter was up 11.7% on a year-over-year basis. As a group, research analysts expect that Maximus, Inc. will post 5.79 earnings per share for the current year.

Maximus Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Friday, May 31st. Shareholders of record on Wednesday, May 15th were paid a dividend of $0.30 per share. The ex-dividend date was Tuesday, May 14th. This represents a $1.20 annualized dividend and a yield of 1.38%. Maximus’s dividend payout ratio (DPR) is presently 31.50%.

Analysts Set New Price Targets

Separately, StockNews.com raised Maximus from a “hold” rating to a “buy” rating in a report on Thursday, February 8th.

View Our Latest Stock Analysis on MMS

Maximus Profile

(Free Report)

Maximus, Inc operates as a provider of government services in the United States and internationally. It operates through three segments: U.S. Federal Services, U.S. Services, and Outside the U.S. The U.S. Services segment offers program eligibility support and enrollment; centralized multilingual customer contact centers, multichannel, and digital self-service options for enrollment; application assistance and independent health plan choice counseling; beneficiary outreach, education, eligibility, enrollment, and redeterminations; and person-centered independent disability, long-term sick, and other health assessments.

Recommended Stories



Receive News & Ratings for Maximus Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for Maximus and related companies with MarketBeat.com’s FREE daily email newsletter.

Source: defenseworld.net

About the author

Amanda

Hi there, I am Amanda and I work as an editor at impactinvesting.ai;  if you are interested in my services, please reach me at amanda.impactinvesting.ai